Lv11
10 积分 2023-03-27 加入
Transport properties of valsartan, sacubitril and its active metabolite (LBQ657) as determinants of disposition
8小时前
已完结
Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic
8个月前
已完结
High-throughput screening identified pacritinib as a promising therapeutic approach to overcome lenvatinib resistance in hepatocellular carcinoma by targeting IRAK1
8个月前
已完结
Identification of an m6A Natural Inhibitor, Lobeline, That Reverses Lenvatinib Resistance in Hepatocellular Tumors
8个月前
已完结
Reserpine, a novel N6-methyladenosine regulator, reverses Lenvatinib resistance in hepatocellular carcinoma
8个月前
已完结
WDR4/TRIM28 is a novel molecular target linked to lenvatinib resistance that helps retain the stem characteristics in hepatocellular carcinomas
8个月前
已完结
Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression
8个月前
已完结
High-throughput screening identified pacritinib as a promising therapeutic approach to overcome lenvatinib resistance in hepatocellular carcinoma by targeting IRAK1
8个月前
已完结
Lenvatinib: A Review in Hepatocellular Carcinoma
10个月前
已完结
Hepatocellular Carcinoma: New Developments
10个月前
已完结
皖公网安备34019202002308
